Account wins from 09/09 News Brief

Share this article:
InChord Communications has been selected to develop and implement the marketing strategy for two new products from nutraceuticals firm Millennium Biotechnologies. InChord will handle U.S. launch of Resurgex and Resurgex-Plus.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.

Doctors back unique biosimilar names

A host of doctors has asked FDA Commissioner Margaret Hamburg to back a naming convention that would require biologics and biosimilars to have different names.

Roche has no rights to Sovaldi, panel rules

Despite a collaboration with original Sovaldi owner Pharmasset in 2004, a panel ruled Roche has no rights to HCV treatment Sovaldi.